通过隔离病例和接触者控制COVID-19暴发的可行性
研究使用随机传播模型评估隔离病例和接触者追踪对控制SARS-CoV-2样病原体输入传播的效果。模拟显示,在多数情景下,高效的接触者追踪和病例隔离足以在3个月内控制新发COVID-19暴发;控制概率随症状出现至隔离延迟延长、追踪到的病例减少以及症状前传播增加而下降。
要点
- R0为1.5时,多数情景下追踪不足50%的接触者即可控制暴发。
- R0为2.5时需追踪超过70%的接触者才能控制多数暴发。
- R0为3.5时需追踪超过90%的接触者才能控制多数暴发。
核心结论
- 在多数情景下,高效的接触者追踪和病例隔离足以在3个月内控制新发COVID-19暴发。
- 控制概率随症状出现至隔离延迟延长、接触者追踪发现的病例减少以及症状前传播增加而下降。
- 该模型可修改以反映更新的传播特征和更具体的暴发控制定义,以评估当地应对工作的潜在成功。
研究设计与样本
- 开发了以COVID-19暴发为参数设置的随机传播模型。
- 模型用于量化接触者追踪和病例隔离在控制SARS-CoV-2样病原体时的潜在有效性。
- 考虑了初始病例数、基本再生数(R0)、症状出现至隔离的延迟、接触者被追踪的概率、症状出现前传播的比例以及亚临床感染比例等变化情景。
- 模型中假设隔离可阻止所有进一步传播。
- 若传播在12周内或总病例数达到5000例之前结束,则判定暴发得到控制。
主要发现
- 模拟暴发以5例初始病例、R0为1.5、症状出现前传播为0%开始,即使接触者追踪概率低也可控制。
- 控制暴发的概率随初始病例数增加而下降。
- 当R0为2.5或3.5时,控制概率下降。
- 症状出现前传播越多,控制概率下降。
- 在不同初始病例数下,R0为1.5的多数情景在成功追踪不足50%接触者时即可控制。
关键数值与推荐
- 暴发控制判定:传播在12周内或总病例数达到5000例之前结束。
- R0为1.5时,多数情景下成功追踪不足50%的接触者即可控制暴发。
- R0为2.5时,需追踪超过70%的接触者才能控制多数暴发。
- R0为3.5时,需追踪超过90%的接触者才能控制多数暴发。
- R0为2.5或3.5且有40例初始病例时,仅当症状出现前传播低于1%时,接触者追踪和隔离才潜在可行。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Isolation of cases and contact tracing is used to control outbreaks of infectious diseases, and has been used for coronavirus disease 2019 (COVID-19). Whether this strategy will achieve control depends on characteristics of both the pathogen and the response. Here we use a mathematical model to assess if isolation and contact tracing are able to control onwards transmission from imported cases of COVID-19. METHODS: We developed a stochastic transmission model, parameterised to the COVID-19 outbreak. We used the model to quantify the potential effectiveness of contact tracing and isolation of cases at controlling a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-like pathogen. We considered scenarios that varied in the number of initial cases, the basic reproduction number (R0), the delay from symptom onset to isolation, the probability that contacts were traced, the proportion of transmission that occurred before symptom onset, and the proportion of subclinical infections. We assumed isolation prevented all further transmission in the model. Outbreaks were deemed controlled if transmission ended within 12 weeks or before 5000 cases in total. We measured the success of controlling outbreaks using isolation and contact tracing, and quantified the weekly maximum number of cases traced to measure feasibility of public health effort. FINDINGS: Simulated outbreaks starting with five initial cases, an R0 of 1·5, and 0% transmission before symptom onset could be controlled even with low contact tracing probability; however, the probability of controlling an outbreak decreased with the number of initial cases, when R0 was 2·5 or 3·5 and with more transmission before symptom onset. Across different initial numbers of cases, the majority of scenarios with an R0 of 1·5 were controllable with less than 50% of contacts successfully traced. To control the majority of outbreaks, for R0 of 2·5 more than 70% of contacts had to be traced, and for an R0 of 3·5 more than 90% of contacts had to be traced. The delay between symptom onset and isolation had the largest role in determining whether an outbreak was controllable when R0 was 1·5. For R0 values of 2·5 or 3·5, if there were 40 initial cases, contact tracing and isolation were only potentially feasible when less than 1% of transmission occurred before symptom onset. INTERPRETATION: In most scenarios, highly effective contact tracing and case isolation is enough to control a new outbreak of COVID-19 within 3 months. The probability of control decreases with long delays from symptom onset to isolation, fewer cases ascertained by contact tracing, and increasing transmission before symptoms. This model can be modified to reflect updated transmission characteristics and more specific definitions of outbreak control to assess the potential success of local response efforts. FUNDING: Wellcome Trust, Global Challenges Research Fund, and Health Data Research UK.
引用
- Hellewell J, Abbott S, Gimma A, et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health. 2020. PMID: 32119825. doi:10.1016/S2214-109X(20)30074-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。